BCL2 and myelodysplastic syndrome: Although the contribution of apoptosis to the pathogenesis of primary MDs is not univocally established, increasing the levels of anti‐apoptotic Bcl‐2 proteins may represent an effective strategy to prolong cell survival and slow down disease progression.